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echanism for controlling EV71 infection. Inﬂammatory
esponse with induction of toxic inﬂammatory cytokines has
een considered as an essential component of the patho-
enesis of EV71, especially the development of neurogenic
E.
Methods: In this study, the role of the type I IFN and proin-
ammatory cytokine responses on the disease development
nd mechanisms of viral evasion were investigated by using
murine model with mouse-adapted EV71 strain.
Results: After EV71 inoculation, the animals devel-
ped viremia, limb paralysis, pulmonary dysfunction, and
mphysema with a signiﬁcant increase of interleukin (IL)-6,
onocyte chemoattractant protein-1, tumor necrosis fac-
or and IFN-/, but not IL-10, IL-12, IL-13, and type I IFNs
n serum and brain. We assumed that sufﬁcient amounts
f PE-associated cytokines (i.e., IL-6, IL-13, and IFN-/) may
e required for the development of EV71-induced PE. The
esults showed that EV71-infected mice with post-treatment
f IL-6, IL-13, and IFN-/developed PE and severe emphysema
ccompanying with a more severe pulmonary dysfunction
han EV71-infected, cytokine non-treated mice. Further-
ore, we observed that mice inoculated with EV71 produced
signiﬁcant lower amount of serum type I IFNs than those
noculated with poly (I:C), adenovirus type V, or Coxsackie
3 virus (CB3). EV71 preinfection abolished both poly (I:C)
nd CB3 induced-type I IFN production, and decreased the
ercentage of IFN-producing plasmacytoid dendritic cells in
lood of CB3-infected mice. In addition, a pre-incubation
f EV71 also reduced poly (I:C) induced-type I IFN produc-
ion of murine monocyte/macrophage cell line, RAW264.7.
he inhibitory effect of EV71 on type I IFN production
as contributed by 3C protease that was proven using
ver-expression systems either in RAW264.7 cell or adult
ouse.
Conclusion: In conclusion, EV71 may block type I IFN syn-
hesis through 3C protease to interfere with host innate
efence, and on the other hand, trigger proinﬂammatory
ytokine responses to promote PE development.
oi:10.1016/j.ijid.2010.02.647
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he study of epidemiological data of varicella and its com-
lications in Albanian children
. Hoxha1,∗, E. Kallfa-Foto1, G. Lito1, R. Petrela1, A.
imaku2
University Hospital Center Mother Theresa Tirana, Alba-
ia, Tirana, Albania
Institute Public Health, Tirana, Albania
Background: Varicella is a serious diseases especially for
ts complications and even death,may occur in healthy chil-
ren. Complication have been estimated at a rate of 29.2 per
0000.The serious problem of varicella are reduced after
ntroduced of the vaccine against varicella. The aims of
his study was to show epidemiological data,risk factors and
omplications of varicella in the Albanian children.Methods: This was a retrospective study and in this study
ere included 68 children aged 0 to 14 years old admit-
ed in University Hospital Center during January 2004 to
ecember 2008.Epidemiological data analysed were: sex,
p
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ge,origin,length of hospitalization,risk factors and compli-
ations.
Results: The mean length of hospitalization was 5.2
ays. Age-group most affected was 1-6 years old with
0 cases or 44.12%,followed by children aged 7-14 years
ld with 22 cases or 32.3%.47 cases or 69.1% were male
nd there were no difference for origin.We observed
his complications: bacterial overinfections: 22 cases or
2.36%(skin and soft tissue infectious caused by S.aureus
nd S. pyogenes) 4 oteoarthritis,neurological complications:
cerebellitis,2 encephalitis,3 status epilepticus, 1 neuri-
is, 12 varicella pneumonia,1 hepatitis, 1 thrombocytopenic
urpura,1 hemolitic anemia. 18 cases or26.45% under one
ears old presented enteritis.Acyclovir was used in 26 cases
r 38.2%.(mainly complicated). We observed risk factors in
cases or (11.8%) as: 3 leucemia,5 atopic dermatitis.
Conclusion: Varicella still remains a frequent infection of
hildhood,which often is followed by serious complications.
he results of this study can contribute to evaluating the
ptions for varicella vaccination.
oi:10.1016/j.ijid.2010.02.648
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atent manifestations in the US Congenital Rubella Syn-
rome (CRS) Population
. Armstrong
Molloy College, Rockville Centre, NY, USA
Background: Since rubella and congenital rubella syn-
rome (CRS) have not been globally eradicated and
opulations who do not vaccinate continue to persist,
ncreasing knowledge about adults with CRS remains of great
mportance. This study investigated the latent CRS manifes-
ations of 174 adults with CRS in the United States, born
efore 1987.
Methods: Cross sectional design. In this study, Helen
eller National Center’s (HKNC) registry was used to identify
ndividuals born with CRS in the United States. Established
hrough an Act of Congress, HKNC is mandated to main-
ain a national registry of persons who are deaf-blind. The
ational database, located at HKNC in New York contains
ersonal (race, marital status, residential status, educa-
ion and employment) and medical (etiology, diagnostic
nd comorbidities) information on more than 10, 000 deaf-
lind individuals with birth dates ranging from 1930-present.
ccording to HKNC, there are approximately 1000 deaf blind
ndividuals 21 and older who are listed as having CRS (HKNC,
006). According to the CDC, this cohort is the result of the
963-1965 rubella epidemic. In addition, the registry lists
13 CRS children, ages birth to 21.
Results: The survey reported the prevalence of medical
isorders including diabetes, cardiac and thyroid dysfunc-
ion and glaucoma. Additionally, psychological symptoms
uch as autisticlike behavior, mood disorder and aggressive
ehavior were reported
Conclusion: CRS is characterized by multiple defects,
articularly to the heart, eyes, ears and brain. In utero,
he rubella-virus can damage the immune system and ves-
els which is a harmful starting point for several diseases
nce the CRS-individual ages. CRS individuals are develop-
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ing both new medical and psychological symptoms as they
age. However, there has been very little information written
about this phenomenon, although late onset medical prob-
lems have been documented, particularly in the Australian
Rubella population born in the 1940 s. The results of this
study are helpful in understanding both medical and psycho-
logical symptoms of the CRS adults, and anticipate potential
diseases and behaviors.
doi:10.1016/j.ijid.2010.02.649
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Inhibition of high risk HPV-31 in human cervical epithelial
cells in vitro by the PC-PLC inhibitor LMV-601
E. Amtmann1,∗, F. Mayer2, H. Pink1, W. Baader1
1 German Cancer Research Centre (DKFZ), Heidelberg, Ger-
many
2 Lumavita AG, Basel, Switzerland
Background: Expression of early genes and episomal DNA
replication of human papilloma virus (HPV) is dependent
from an active AP1 complex. Activation of AP1 was shown
to be precluded by inhibition of phosphatidylcholine spe-
ciﬁc phospholipase C (PC-PLC). We studied the effect of
the PC-PLC inhibitor LMV-601 on HPV-31 infected 9E cervical
epithelial cells (CIN 612 9E).
LMV-601 is (-)-exo/exo-O-Tricyclo-[5.2.1.0(2,6)]-dec-9-
yl-dithiocarbonate potassium salt. Tricyclo-[5.2.1.0(2,6)]-
dec-9-yl-dithiocarbonate potassium salt consists of 8
isomers (4 diastereomers, each having 2 enantiomers) and
became known under the code D609, ﬁrst synthesized in
1984 by Merz and Co in co-operation with the German Can-
cer Research Centre (DKFZ). The pure (-)-exo/exo isomer
was ﬁrst isolated in 2006 and is developed by Lumavita AG
as an antiviral drug.
Methods: 9E HPV-31 infected cervical epithelial cells
were from L.A. Laimins, Chicago.
(a) Short term study: After 72 h treatment, effect on cell
growth, HPV-31 speciﬁc DNA (Southern Blotting) and RNA
(Northern Blotting) was assessed.
(b) Long term treatment (9 passages): After each pas-
sage, viral RNA and DNA levels, and cell morphology were
assessed.
Results: (a) Short term study: LMV-601 displayed a dose
dependent inhibitory effect on cell growth(IC50 16 !g/mL),
HPV-31 speciﬁc RNA expression (IC50 10.69 !g/mL) and DNA
content (62.5% reduction at the highest dose tested, i.e. 32
!g/mL).
(b) Long term treatment: The number of passages
required to reduce the amount of HPV-31 speciﬁc RNA by
50% (T50RNA) was 2.23 at 3.3 !g/mL LMV-601 and < 1 at 10
!g/mL LMV-601. The corresponding T50DNA values were 3.28
and < 1, respectively.
After six passages the growth rate of the cells was
reduced and the morphology of the cells changed from the
spindle form to a normal phenotype. After passage 9, cells
were enlarged, became senescent (identiﬁed by expres-
sion of the senescence marker beta-gal), and ceased to
grow.
When human, non-HPV immortalized HaCat ker-
atinocytes were treated with the same concentrations of
p
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MV-601, neither cumulative inhibition of growth rate nor
nduction of senescence could be observed.
Conclusion: LMV-601 inhibits HPV-31 speciﬁc RNA expres-
ion and DNA replication. Furthermore, these results
upport the hypothesis that chronic treatment with LMV-601
‘cures’’ pre-cancerous 9E keratinocytes by elimination of
PV genomes.
oi:10.1016/j.ijid.2010.02.650
4.020
he pain topography caused by misdiagnosed zoster
. Duraku1, N. Como2,∗, E. Meta1, D. Kraja3, A. Kica1
HUC, Tirane, Albania
University Hospital Centre ‘‘Mother Theresa’’, Tirana, AL,
lbania
Faculty of Medicine, Tirane, Albania
Background: In Herpes Zoster, the pain precedes der-
atome manifestation from 10—12 hours to 2—5 days even
o 10 days. Zosterian pain last, however it’s intermittent.
ur goal in this study is in highlighting the topographic vari-
ty of Zosterian pain and initial misdiagnose related with
t.
In this study we have included 202 cases of Herpes Zoster.
7 of the them were initially not identiﬁed as Herpes Zoster.
he group age was 19—78 years old, time period from
998—2009. 37 of them were HIV positive. In our cases pain
recedes exantematic manifestation from 18 to 68 hours.
Methods: The cases were assessed based on correlation
etween neurotics zosterian pain and initial nosology.
Results: According to pain location we distinguished
hese initial misdiagnoses:
ocation Diagnosis Number of cases
ead migraine 8
inusitis frontal 2
titis 2
phtalmitis 3
rthritis temporo — mandibular1
dontalgya 2
horax angina pectoris 3
ericarditis 2
leuritis 13
neumonia 11
bdomen abdominal colic 6
idney colic 4
epatic colic 4
holecystitis 2
ezenterial thrombosis 1
rchitis 2
pper extremites cervical racialgya5
ervical spondylarthrose 7
horax racialgya 6
capulo-humeral bursitis 2
ower extremites ischialgya 7
iscal hernia 1
ngiopathies 2
olymialgya rheumatica 1
oxo-femoral arthritis 2
Conclusion: 1) Zoster cases identiﬁed wrong initially were
8.02%.
